US states are piling more pressure onto private equity healthcare teams. Plus: a new Vitruvian man; and Carlyle co-founder David Rubenstein has come into some liquidity. Here's today's brief, for our valued subscribers only.
Japan could be in contention for Advent’s next stage of Asia-Pacific expansion after the firm’s newly opened Australia office, India head Shweta Jalan tells PEI.
CalPERS staff explain why they're betting billions on emerging managers. Plus: Alaska's PE director receives an expanded investment remit; and LPs are becoming much more optimistic about distributions. Here's today's brief, for our valued subscribers only.
The Paris-based manager is set to be back in the market with its sophomore secondaries fund in early 2025, following closes for its flagship and emerging manager funds.
Co-investors often have different expectations and preferences than main fund investors when it comes to GP-led secondaries processes, write Debevoise's Jane Engelhardt, Brett Bush and Lauren Heller.
Fundraising for healthcare vehicles almost doubled last year and our latest special report examines where the money will be spent. Plus: LP portfolio management on the up and Temasek subsidiary's credit move. Here's today's brief, for our valued subscribers only.
In wake of Fifth Circuit decision, rules should be scrapped or carve out private fund managers, groups claim.
The world's largest PE investor says it is guided by thematic investing, and does not have a target allocation for the asset class. Plus: the firm that's doubled each fund size since inception; and BlackRock's thoughts on AI. Here's today's brief, for our valued subscribers only.
London-based private equity houses should prepare for a wide range of scenarios ahead of the 2024 autumn statement.
Exit activity across the industry will continue to pick up over the second half of this year, says the firm’s chairman of Europe Nikos Stathopoulos.